LFTD Partners Inc. ( LIFD) - Key Metrics
LIFD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.59 | -$0.10 | -$0.04 | -$0.04 |
| 2026Q1 | $0.62 | -$0.28 | $0.03 | $0.02 |
| 2025Q4 | $0.57 | -$1.68 | $0.04 | $0.03 |
| 2025Q3 | $0.61 | $0.04 | $0.05 | $0.05 |
| 2025Q2 | $0.70 | -$0.02 | -$0.02 | -$0.02 |
LIFD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -0.31% | -0.51 |
| 2026Q1 | -0.07% | -0.21 |
| 2025Q4 | -0.01% | -0.03 |
| 2025Q3 | 0.71% | 1.70 |
| 2025Q2 | -1.67% | -5.39 |
LIFD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -19.37% | 0.15% |
| 2026Q1 | 9.53% | 0.08% |
| 2025Q4 | 17.82% | 0.05% |
| 2025Q3 | 16.20% | 0.10% |
| 2025Q2 | -4.72% | 0.08% |
LIFD
Price: $0.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -4
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.5 million